Qi Wang

Prof. Qi Wang

State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China
+1
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2021 in Susmat
Verified
Journal Article
Open access
PDF file
CZChuhong Zhang
Chuhong Zhang
YLYijun Li
Yijun Li
WKWenbin Kang
Wenbin Kang
XLXingang Liu
Xingang Liu
QWQi Wang
Qi Wang
Three‐dimensional (3D) printing has received extensive attention due to its unique multidimensional functionality and customizability and has been recognized as one of the most revolutionary manufacturing technologies. Functional 3D printed products represent an important orientation for next‐generation manufacturing and attract a great spotlight for the application in sensors, actuators, robots, electronics, and medical devices. However, the lack of functions of printing polymeric materials dramatically limits the development of functional 3D printing. Different from traditional processing, the physical properties, such as geometry and rheological behavior, of the polymeric materials must match the printing process, making the selection of printable materials limited. More importantly, challenges in large‐scale production of such materials further stifle the development of functional 3D printing industry. In this review, we aim to outline recent advances in polymeric materials and methodologies for the functional 3D printing technology. The reports are classified based on functionalities, including electronic conductive, thermally conductive, electromagnetic interference shielding, energy storage, and energy harvesting materials. This study attempts to provide a comprehensive overview of the challenges and opportunities for 3D printing functional polymeric materials/devices, also seeks to enlighten the orientation of future research in this field.

14 April 2004 in Journal of Applied Polymer Science
Verified
Journal Article
Closed access
PDF file
HXHesheng Xia
Hesheng Xia
QWQi Wang
Qi Wang
KLKanshe Li
Kanshe Li
GHGuo‐Hua Hu
Guo‐Hua Hu

28 February 2024 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
HDHao Dong
Hao Dong
YSYuezhang Sun
Yuezhang Sun
LNLulingxiao Nie
Lulingxiao Nie
ACAimin Cui
Aimin Cui
PZPengfei Zhao
Pengfei Zhao
QWQi Wang
Qi Wang
Metabolic diseases and their complications impose health and economic burdens worldwide. Evidence from past experimental studies and clinical trials suggests our body may have the ability to remember the past metabolic environment, such as hyperglycemia or hyperlipidemia, thus leading to chronic inflammatory disorders and other diseases even after the elimination of these metabolic environments. The long-term effects of that aberrant metabolism on the body have been summarized as metabolic memory and are found to assume a crucial role in states of health and disease. Multiple molecular mechanisms collectively participate in metabolic memory management, resulting in different cellular alterations as well as tissue and organ dysfunctions, culminating in disease progression and even affecting offspring. The elucidation and expansion of the concept of metabolic memory provides more comprehensive insight into pathogenic mechanisms underlying metabolic diseases and complications and promises to be a new target in disease detection and management. Here, we retrace the history of relevant research on metabolic memory and summarize its salient characteristics. We provide a detailed discussion of the mechanisms by which metabolic memory may be involved in disease development at molecular, cellular, and organ levels, with emphasis on the impact of epigenetic modulations. Finally, we present some of the pivotal findings arguing in favor of targeting metabolic memory to develop therapeutic strategies for metabolic diseases and provide the latest reflections on the consequences of metabolic memory as well as their implications for human health and diseases.

24 March 2021 in International Journal of Oral Science
Verified
Journal Article
Open access
PDF file
QWQian Wang
Qian Wang
LNLulingxiao Nie
Lulingxiao Nie
PZPengfei Zhao
Pengfei Zhao
XZXinyi Zhou
Xinyi Zhou
YDYi Ding
Yi Ding
QWQi Wang
Qi Wang
Hyperglycemia induces chronic low-grade inflammation (inflammaging), which is a newly identified contributor to diabetes-related tissue lesions, including the inflammatory bone loss in periodontitis. It is also a secondary senescent pattern mediated by an increased burden of senescent cells and senescence-associated secretory phenotype (SASP). Macrophage is a key SASP-spreading cell and may contribute to the maintenance of SASP response in the periodontal microenvironment. Using a transgenic diabetic model (BLKS/J-Leprdb/leprdb mice) we identified striking senescence of the periodontium in young (18-wk)-diabetic mice accompanied by amassed p16+-macrophages and enhanced early SASP response. Exposed to high glucose in vitro, bone marrow-derived macrophage (BMDM) revealed a strong GLUT1 mRNA response driving the elevated-glucose uptake. GLUT1 is a representative and facilitative glucose transporter in macrophages with potential roles in hyperglycemia-induced inflammation. In this study, both GLUT1 and the downstream GTPase Rheb expression upregulated in the gingiva of diabetic mice with impaired condition. Furthermore, SASP release and p16/p21 signaling were proven to be triggered by mTOR phosphorylation in BMDM and antagonized by restricting glucose uptake in GLUT1−/− BMDM. Taken together, our findings suggest that elevated-GLUT1 sensor responded to high glucose is important for macrophage senescence and SASP response, generated as a result of hyperglycemia, and it is a potential molecular mechanism for the exacerbation of periodontitis in diabetes.

22 December 2005 in Macromolecular Materials and Engineering
Verified
Journal Article
Closed access
PDF file
GQGuihua Qiu
Guihua Qiu
QWQi Wang
Qi Wang
MNMin Nie
Min Nie

4 October 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
ZYZiqi Yue
Ziqi Yue
LNLulingxiao Nie
Lulingxiao Nie
PZPengfei Zhao
Pengfei Zhao
NJNing Ji
Ning Ji
GLGa Liao
Ga Liao
QWQi Wang
Qi Wang
The senescence-associated secretory phenotype (SASP), which accumulates over the course of normal aging and in age-related diseases, is a crucial driver of chronic inflammation and aging phenotypes. It is also responsible for the pathogenesis of multiple oral diseases. However, the pathogenic mechanism underlying SASP has not yet been fully elucidated. Here, relevant articles on SASP published over the last five years (2017–2022) were retrieved and used for bibliometric analysis, for the first time, to examine SASP composition. More than half of the relevant articles focus on various cytokines (27.5%), growth factors (20.9%), and proteases (20.9%). In addition, lipid metabolites (13.1%) and extracellular vesicles (6.5%) have received increasing attention over the past five years, and have been recognized as novel SASP categories. Based on this, we summarize the evidences demonstrating that SASP plays a pleiotropic role in oral immunity and propose a four-step hypothetical framework for the progression of SASP-related oral pathology—1) oral SASP development, 2) SASP-related oral pathological alterations, 3) pathological changes leading to oral immune homeostasis disruption, and 4) SASP-mediated immune dysregulation escalating oral disease. By targeting specific SASP factors, potential therapies can be developed to treat oral and age-related diseases.